Cargando…
The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma
INTRODUCTION: Febrile neutropenia (FN) is a potential life-threatening complication of myelosuppressive chemotherapy, particularly when induced by infection. There is evidence that FN can originate from the oral cavity, but its contribution to FN is largely understudied in patients treated for solid...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280026/ https://www.ncbi.nlm.nih.gov/pubmed/35846111 http://dx.doi.org/10.3389/froh.2022.940044 |
_version_ | 1784746541582385152 |
---|---|
author | Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. de Lange, Jan Smeele, Ludi E. |
author_facet | Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. de Lange, Jan Smeele, Ludi E. |
author_sort | Zecha, Judith A. E. M. |
collection | PubMed |
description | INTRODUCTION: Febrile neutropenia (FN) is a potential life-threatening complication of myelosuppressive chemotherapy, particularly when induced by infection. There is evidence that FN can originate from the oral cavity, but its contribution to FN is largely understudied in patients treated for solid tumors. The aim of this study was to assess the prevalence of FN in these patients and to evaluate its relation with dental foci and oral mucositis. MATERIAL AND METHODS: A prospective longitudinal observational study was conducted. Patients diagnosed with solid tumors and lymphoma scheduled to be treated with myelosuppressive chemotherapy with an intermediate risk of developing FN were included. A pre-chemotherapy dental examination was performed and patients were followed during and after chemotherapy regimen. During subsequent hospital visits for chemotherapy administration, the oral cavity was inspected and oral mucositis (OM) was scored using the CTC-AE version 3.0. When patients presented with fever, a comprehensive full body examination including laboratory/microbiological/imaging investigation was performed. RESULTS: Eighty-eight patients were included. Pre-chemotherapy, 39 patients (44.3%) were diagnosed with a dental focus. During chemotherapy, 46 patients developed OM (53.4%), of which 15 patients had a maximum score of grade II (ulcerative mucositis). Ten patients developed FN during the follow-up period. Patients with FN more often suffered from ulcerative OM compared to patients without FN; both FN and mucositis risk was associated with the myelotoxicity of chemotherapy. However, no relation could be established between the presence of dental foci prior to chemotherapy and the development of FN (p > 0.05). CONCLUSION: A significant relation was identified between ulcerative OM and FN, but no robust conclusions could be drawn with respect to a relationship between the presence of dental foci and FN. |
format | Online Article Text |
id | pubmed-9280026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92800262022-07-15 The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. de Lange, Jan Smeele, Ludi E. Front Oral Health Oral Health INTRODUCTION: Febrile neutropenia (FN) is a potential life-threatening complication of myelosuppressive chemotherapy, particularly when induced by infection. There is evidence that FN can originate from the oral cavity, but its contribution to FN is largely understudied in patients treated for solid tumors. The aim of this study was to assess the prevalence of FN in these patients and to evaluate its relation with dental foci and oral mucositis. MATERIAL AND METHODS: A prospective longitudinal observational study was conducted. Patients diagnosed with solid tumors and lymphoma scheduled to be treated with myelosuppressive chemotherapy with an intermediate risk of developing FN were included. A pre-chemotherapy dental examination was performed and patients were followed during and after chemotherapy regimen. During subsequent hospital visits for chemotherapy administration, the oral cavity was inspected and oral mucositis (OM) was scored using the CTC-AE version 3.0. When patients presented with fever, a comprehensive full body examination including laboratory/microbiological/imaging investigation was performed. RESULTS: Eighty-eight patients were included. Pre-chemotherapy, 39 patients (44.3%) were diagnosed with a dental focus. During chemotherapy, 46 patients developed OM (53.4%), of which 15 patients had a maximum score of grade II (ulcerative mucositis). Ten patients developed FN during the follow-up period. Patients with FN more often suffered from ulcerative OM compared to patients without FN; both FN and mucositis risk was associated with the myelotoxicity of chemotherapy. However, no relation could be established between the presence of dental foci prior to chemotherapy and the development of FN (p > 0.05). CONCLUSION: A significant relation was identified between ulcerative OM and FN, but no robust conclusions could be drawn with respect to a relationship between the presence of dental foci and FN. Frontiers Media S.A. 2022-06-30 /pmc/articles/PMC9280026/ /pubmed/35846111 http://dx.doi.org/10.3389/froh.2022.940044 Text en Copyright © 2022 Zecha, Raber-Durlacher, Laheij, Westermann, de Lange and Smeele. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oral Health Zecha, Judith A. E. M. Raber-Durlacher, Judith E. Laheij, Alexa M. G. A. Westermann, Anneke M. de Lange, Jan Smeele, Ludi E. The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma |
title | The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma |
title_full | The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma |
title_fullStr | The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma |
title_full_unstemmed | The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma |
title_short | The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma |
title_sort | potential contribution of dental foci and oral mucositis to febrile neutropenia in patients treated with myelosuppressive chemotherapy for solid tumors and lymphoma |
topic | Oral Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280026/ https://www.ncbi.nlm.nih.gov/pubmed/35846111 http://dx.doi.org/10.3389/froh.2022.940044 |
work_keys_str_mv | AT zechajudithaem thepotentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT raberdurlacherjudithe thepotentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT laheijalexamga thepotentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT westermannannekem thepotentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT delangejan thepotentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT smeeleludie thepotentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT zechajudithaem potentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT raberdurlacherjudithe potentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT laheijalexamga potentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT westermannannekem potentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT delangejan potentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma AT smeeleludie potentialcontributionofdentalfociandoralmucositistofebrileneutropeniainpatientstreatedwithmyelosuppressivechemotherapyforsolidtumorsandlymphoma |